NYU Langone Medical Center - Cancer Institute — New York, New York

NYU Langone Medical Center - Cancer Institute is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

NYU Langone Medical Center - Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone Medical Center - Cancer Institute?

NYU Langone Medical Center - Cancer Institute has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone Medical Center - Cancer Institute conducted?

NYU Langone Medical Center - Cancer Institute has 1 clinical trials on record. Their work covers Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Is NYU Langone Medical Center - Cancer Institute accredited by Crixeo Health?

NYU Langone Medical Center - Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone Medical Center - Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.